Survival prediction for pancreatic cancer patients receiving gemcitabine treatment.
Matsubara J, Ono M, Honda K, Negishi A, Ueno H, Okusaka T, Furuse J, Furuta K, Sugiyama E, Saito Y, Kaniwa N, Sawada J, Shoji A, Sakuma T, Chiba T, Saijo N, Hirohashi S, Yamada T.
Matsubara J, et al. Among authors: honda k.
Mol Cell Proteomics. 2010 Apr;9(4):695-704. doi: 10.1074/mcp.M900234-MCP200. Epub 2010 Jan 8.
Mol Cell Proteomics. 2010.
PMID: 20061307
Free PMC article.